COVID-19 Implications For The OTC Derivatives Markets

KL
Kramer Levin Naftalis & Frankel LLP
Contributor
Kramer Levin provides its clients proactive, creative and pragmatic solutions that address today’s most challenging legal issues. The firm is headquartered in New York with offices in Silicon Valley and Paris and fosters a strong culture of involvement in public and community service. For more information, visit www.kramerlevin.com
Corporate partners Fabien Carruzzo and Gilles Kolifrath, associates Daniel King, Jeruska Lugo Sánchez and Linda Sharkey authored a Lexis Practice Advisor article titled...
United States Coronavirus (COVID-19)
To print this article, all you need is to be registered or login on Mondaq.com.

Corporate partners Fabien Carruzzo and Gilles Kolifrath, associates Daniel King, Jeruska Lugo Sánchez and Linda Sharkey authored a Lexis Practice Advisor article titled "COVID-19 Implications for the OTC Derivatives Markets" in May 2020. The article examines a number of issues for market participants to consider in the event of disruptions and volatility in the markets.

Read the full article here.


Article originally published on 28 May 2020

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

COVID-19 Implications For The OTC Derivatives Markets

United States Coronavirus (COVID-19)
Contributor
Kramer Levin provides its clients proactive, creative and pragmatic solutions that address today’s most challenging legal issues. The firm is headquartered in New York with offices in Silicon Valley and Paris and fosters a strong culture of involvement in public and community service. For more information, visit www.kramerlevin.com
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More